89 patents
Page 3 of 5
Utility
Compounds and Uses Thereof
1 Apr 21
Carrie A. Bowen, Douglas F. Burdi, Michele L. R. Heffernan, Lee W. Herman, Linghong Xie
Filed: 12 Aug 20
Utility
Methods of treating Parkinson's disease by administration of apomorphine to an oral mucosa
30 Mar 21
Methods and pharmaceutical unit dosage forms for treating Parkinson's disease in a subject (e.g., an “off” episode in a subject having Parkinson's disease) are described.
Scott David Barnhart, Michael Clinton Koons, Madhu Sudan Hariharan, Jordan Dubow, Thierry Bilbault, Anthony John Giovinazzo
Filed: 9 Sep 19
Utility
Crystal Forms and Production Methods Thereof
4 Mar 21
The various aspects present inventions provide various crystalline forms of (S)-(−)-amisulpride, (R)-(+)-amisulpride, and solvates thereof and methods of making same.
John R. Snoonian, Harold Scott Wilkinson, Haitao Zhang
Filed: 17 Aug 20
Utility
Salts, Crystal Forms, and Production Methods Thereof
25 Feb 21
Provided are salts of (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine and various of crystal forms thereof, and compositions, medicaments, pharmaceutically acceptable formulations thereof, and methods of making same.
Andrea BAUER, Nandkumar Nivritti BHOGLE, Xiaoxia CHEN, Shahla JAMZAD, Robert Joseph PRYTKO, Kostas SARANTEAS, Michael Joseph SIZENSKY, Harold Scott WILKINSON, Haitao ZHANG
Filed: 28 Aug 20
Utility
Compounds and compositions and uses thereof
23 Feb 21
Linghong Xie, Michele L. R. Heffernan, Philip Glyn Jones, Taleen G. Hanania
Filed: 10 Dec 18
Utility
TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE
18 Feb 21
Treatment of CNS disorders with (1R,4S)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine; and (1S,4R)-trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine is disclosed.
Thomas JERUSSI, Qun Kevin FANG, Mark G. CURRIE
Filed: 2 Jun 20
Utility
Multicyclic compounds and methods of use thereof
19 Jan 21
Provided herein are multicyclic compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use.
Liming Shao, John Emmerson Campbell, Michael Charles Hewitt, Una Campbell, Taleen G. Hanania
Filed: 14 Feb 20
Utility
Methods of Treating Social Function Disorders
14 Jan 21
David BLUM
Filed: 15 Feb 19
Utility
Easy-open Peel Pouch
6 Jan 21
Embodiments include a package for containing and dispensing a product.
Julie A. CARDIN, Edward Emmett CHAPDELAINE, Steven A. RAU
Filed: 22 Sep 20
Utility
Oral Dosage Forms
30 Dec 20
The present application generally relates to pharmaceutical compositions comprising dasotraline, and methods of using the pharmaceutical compositions thereof to treat disorders, while limiting a perceived bitter taste or paresthesic sensation.
Maiko ONITA, Shahla JAMZAD
Filed: 17 Jan 19
Utility
Nonracemic mixtures and uses thereof
28 Dec 20
Provided are compositions comprising unequal mixtures of (R)-amisulpride and (S)-amisulpride, or pharmaceutically acceptable salts thereof, where the amount of (R)-amisulpride is greater than the amount of (S)-amisulpride, compositions and medicaments comprising the same used for the treatment of various diseases and disorders, and methods of using same for the treatment of various diseases and disorders, including, but not limited to, dosage regimens.
Seth Cabot Hopkins, Kenneth Stephen Koblan, John R. Snoonian, Harold Scott Wilkinson
Filed: 12 Apr 20
Utility
Modified Release Formulations and Uses Thereof
9 Dec 20
Provided are modified release compositions in a solid oral dosage form comprising amisulpride in the form of an unequal mixture of (R)-amisulpride and (S)-amisulpride, or pharmaceutically acceptable salts thereof, where the amount of (R)-amisulpride is greater than the amount of (S)-amisulpride, and medicaments comprising the same used for the treatment of various diseases and disorders, and methods of using same for the treatment of various diseases and disorders, including, but not limited to, dosage regimens.
Takumi Asada, Gerald R. Galluppi, Seth Cabot Hopkins, Megumi Maruyama, Siriporn Toongsuwan, Yuki Tsushima
Filed: 3 Jun 20
Utility
Easy-open peel pouch
26 Oct 20
Embodiments include a package for containing and dispensing a product.
Julie A. Cardin, Edward Emmett Chapdelaine, Steven A. Rau
Filed: 6 Jun 17
Utility
Salts, crystal forms, and production methods thereof
26 Oct 20
Provided are salts of (S)-(4,5-dihydro-7H-thieno[2,3-c]pyran-7-yl)-N-methylmethanamine and various of crystal forms thereof, and compositions, medicaments, pharmaceutically acceptable formulations thereof, and methods of making same.
Andrea Bauer, Xiaoxia Chen, Shahla Jamzad, Robert Joseph Prytko, Michael Joseph Sizensky, Haitao Zhang
Filed: 14 Feb 19
Utility
Nebulizer Monitoring Device, System and Method
21 Oct 20
Described herein are devices, systems and methods for monitoring the use of a nebulized medication, such as can be administered using a nebulizer.
Michael SEGAL, Nathan ABEL, Spencer BROWN, Everett CROSLAND, Francisco Javier de ANA ARBELOA, Thomas GOODIN, Joseph GORDON, Michael METZ, Daniel NELSON, Jae Hong PARK, Sean SCANLON, Janis SKUJINS, Jennet TOYJANOVA
Filed: 21 Apr 19
Utility
Multicyclic Compounds and Methods of Use Thereof
14 Oct 20
Provided herein are multicyclic compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use.
Liming SHAO, John Emmerson CAMPBELL, Michael Charles HEWITT, Una CAMPBELL, Taleen G. HANANIA
Filed: 13 Feb 20
Utility
Crystal forms and production methods thereof
12 Oct 20
The various aspects present inventions provide various crystalline forms of (S)-(−)-amisulpride, (R)-(+)-amisulpride, and solvates thereof and methods of making same.
John R. Snoonian, Harold Scott Wilkinson, Haitao Zhang
Filed: 21 Jan 20
Utility
Compounds and uses thereof
21 Sep 20
Carrie A. Bowen, Douglas F. Burdi, Michele L. R. Heffernan, Lee W. Herman, Linghong Xie
Filed: 31 Jul 18
Utility
Salts of a Heterocyclic Compound and Crystalline Forms, Processes for Preparing, Therapeutic Uses, and Pharmaceutical Compositions Thereof
16 Sep 20
The present disclosure relates to salts of (R)-1-(8-fluoroisochroman-1-yl)-N-methylmethanamine, crystalline forms thereof, and methods of preparation thereof, which are useful in the treatment of CNS disorders.
Nandkumar Nivritti BHOGLE, Takahiko HASHIZUKA, Robert Joseph PRYTKO, John R. SNOONIAN, Harold Scott WILKINSON, Haitao ZHANG
Filed: 12 Mar 20
Utility
Heteroaryl Compounds and Methods of Use Thereof
2 Sep 20
Provided herein are thiophene compounds, methods of their synthesis, pharmaceutical compositions comprising the compounds, and methods of their use.
John Emmerson CAMPBELL, Una CAMPBELL, Taleen G. HANANIA, Liming SHAO
Filed: 19 Dec 19